The value of next-generation metagenomic sequencing in pathogen detection of pleural effusions and ascites from children with sepsis

被引:2
|
作者
Liu, Gang [1 ]
Wang, Lijuan [1 ]
Li, Xuming [2 ]
Zhang, Ye [2 ]
Long, Hu [2 ]
Wang, Yi [1 ]
Gao, Hengmiao [1 ]
Xia, Han [2 ]
Qian, Suyun [1 ]
机构
[1] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Pediat Intens Care Unit, Beijing, Peoples R China
[2] HugoBiotech Co Ltd, Dept Sci Affairs, Beijing, Peoples R China
关键词
metagenomic next-generation sequencing (mNGS); pathogen detection; children; pleural effusions and ascites; sepsis; FLUID; PROCALCITONIN; PERITONEAL; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1130483
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectiveTo investigate the diagnostic value of metagenomic next-generation sequencing (mNGS) using pleural effusion and ascites from children with sepsis. MethodsIn this study, children with sepsis or severe sepsis and appeared pleural or peritoneal effusions were enrolled, of whom the pleural effusions or ascites and blood samples were conducted pathogen detection using both conventional and mNGS methods. The samples were divided into pathogen-consistent and pathogen-inconsistent groups based on the consistency of mNGS results from different sample types, and into exudate and transudate groups based on their pleural effusion and ascites properties. The pathogen positive rates, pathogen spectrum, consistency between different sample types, and clinical diagnosis consistency were compared between mNGS and conventional pathogen tests. ResultsA total of 42 pleural effusions or ascites and 50 other type samples were collected from 32 children. The pathogen positive rate of the mNGS test was significantly higher than that of traditional methods (78.57% vs. 14.29%, P < 0.001) in pleural effusion and ascites samples, with a consistent rate of 66.67% between the two methods. Nearly 78.79% (26/33) of mNGS positive results of the pleural effusions and ascites samples were consistent with clinical evaluation, and 81.82% (27/33) of these positive samples reported 1-3 pathogens. The pathogen-consistent group outperformed the pathogen-inconsistent group in terms of consistency with respect to clinical evaluation (88.46% vs. 57.14%, P = 0.093), while there was no significant difference between the exudate and transudate groups (66.67% vs. 50.00%, P = 0.483). ConclusionCompared to conventional methods, mNGS has great advantages in pathogen detection of pleural effusion and ascites samples. Moreover, consistent results of mNGS tests with different sample types provide more reference values in clinical diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection
    Gu, Wei
    Miller, Steve
    Chiu, Charles Y.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14, 2019, 14 : 319 - 338
  • [2] Pathogen Detection Using Metagenomic Next-Generation Sequencing of Plasma Samples from Patients with Sepsis in Uganda
    Grundy, Brian S.
    Parikh, Hardik
    Jacob, Shevin
    Banura, Patrick
    Moore, Chris C.
    Liu, Jie
    Houpt, Eric R.
    [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [3] Metagenomic next-generation sequencing for pleural effusions induced by viral pleurisy: A case report
    Liu, Xue-Ping
    Mao, Chen-Xue
    Wang, Guan-Song
    Zhang, Ming-Zhou
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (04) : 844 - 851
  • [4] Metagenomic next-generation sequencing for pleural effusions induced by viral pleurisy: A case report
    Xue-Ping Liu
    Chen-Xue Mao
    Guan-Song Wang
    Ming-Zhou Zhang
    [J]. World Journal of Clinical Cases, 2023, (04) : 844 - 851
  • [5] Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection
    Qin, Cuihong
    Zhang, Shuguang
    Zhao, Yingying
    Ding, Xianfei
    Yang, Fei
    Zhao, Yangchao
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [6] Clinical Value of Metagenomic Next-Generation Sequencing in Immunocompromised Patients with Sepsis
    Cheng, Zheng
    Yu, Feng
    [J]. MEDICAL SCIENCE MONITOR, 2022, 28
  • [7] Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection
    Schlaberg, Robert
    Chiu, Charles Y.
    Miller, Steve
    Procop, Gary W.
    Weinstock, George
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 776 - 786
  • [8] Risk Factors and Outcome of Sepsis in Traumatic Patients and Pathogen Detection Using Metagenomic Next-Generation Sequencing
    Tong, Yiqing
    Zhang, Jianming
    Fu, Yimu
    He, Xingxing
    Feng, Qiming
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [9] Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
    Gu, Wei
    Deng, Xianding
    Lee, Marco
    Sucu, Yasemin D.
    Arevalo, Shaun
    Stryke, Doug
    Federman, Scot
    Gopez, Allan
    Reyes, Kevin
    Zorn, Kelsey
    Sample, Hannah
    Yu, Guixia
    Ishpuniani, Gurpreet
    Briggs, Benjamin
    Chow, Eric D.
    Berger, Amy
    Wilson, Michael R.
    Wang, Candace
    Hsu, Elaine
    Miller, Steve
    DeRisi, Joseph L.
    Chiu, Charles Y.
    [J]. NATURE MEDICINE, 2021, 27 (01) : 115 - +
  • [10] Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
    Wei Gu
    Xianding Deng
    Marco Lee
    Yasemin D. Sucu
    Shaun Arevalo
    Doug Stryke
    Scot Federman
    Allan Gopez
    Kevin Reyes
    Kelsey Zorn
    Hannah Sample
    Guixia Yu
    Gurpreet Ishpuniani
    Benjamin Briggs
    Eric D. Chow
    Amy Berger
    Michael R. Wilson
    Candace Wang
    Elaine Hsu
    Steve Miller
    Joseph L. DeRisi
    Charles Y. Chiu
    [J]. Nature Medicine, 2021, 27 : 115 - 124